The second Spanish biotech company most endorsed by investors last year was the Valencian Arthex Biotech, protagonist of a round of 42 million. Specialized in therapies...
Arthex Biotech is a spin-off of the University of Valencia (UV). Established in September 2019, the company focuses on the development of a treatment for myotonic...
Arthex Biotech is a spin-off of the University of Valencia (UV). Incorporated in September 2019, the company has its focus on the development of a treatment...